http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0765171-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9189a0ff62c994b3beb368015942b88a |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 |
| filingDate | 1994-03-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6ccc39389740b57e88bc1039230c1f80 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f23343a31cabc3944707e61d3b0136dd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0748df4494d4fe52beba8ea64d284b79 |
| publicationDate | 1997-04-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-0765171-A1 |
| titleOfInvention | Treatment of autoimmune and inflammatory disorders |
| abstract | A method for treating autoimmune or inflammatory diseases, through the administration of a CD4+ T cell inhibiting agent, such as anti-CD4 antibody or cyclosporin A, in conjunction with or sequentially to a TNF antagonist, such as anti-TNF antibody or soluble TNF receptor, is disclosed. The method can be used to aid in therapy for humans and other mammals with a wide variety of autoimmune or inflammatory diseases. |
| priorityDate | 1993-10-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 227.